ProKidney Corp. Stock Analysis & AI Score
ProKidney Corp. (PROK) has an ST Score of 46.2 (C+), driven by its Forecast (A) and held back by its Growth (F). Analysts rate it Buy with a $4.67 price target (+178.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
ProKidney Corp. (PROK) has an ST Score of 46.2 (C+), driven by its Forecast (A) and held back by its Growth (F). Analysts rate it Buy with a $4.67 price target (+178.0% upside).
- Strongest
- ForecastA
- Weakest
- GrowthF
All factor grades
- ForecastA
- Financial StrengthA-
- ProfitabilityB-
- ValuationC+
- MomentumC
- GrowthF
- Piotroski1/9
Contact
PROK stock: frequently asked questions
What is PROK's ST Score?
ProKidney Corp. (PROK) has an ST Score of 46.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PROK a buy, hold, or sell?
Analysts rate PROK a Buy, with a price target of $4.67 (+178.0% vs the current price). Our ST Score grades it C+ (46.2/100). The ST Score is a data-driven signal, not a recommendation.
What are PROK's factor grades?
Valuation C+, Profitability B-, Financial Strength A-, Momentum C, Growth F, Forecast A.
What is PROK's valuation grade?
ProKidney Corp. (PROK) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PROK's growth grade?
ProKidney Corp. (PROK) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PROK's profitability grade?
ProKidney Corp. (PROK) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PROK's financial strength grade?
ProKidney Corp. (PROK) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PROK?
The average analyst price target for ProKidney Corp. (PROK) is $4.67 from 8 analysts, which is +178.0% versus the recent price of $1.68.
What is PROK's Piotroski score?
ProKidney Corp. (PROK) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.